Fax: (212) 305-9413
Original Article
You have full text access to this OnlineOpen article
Prevalence and predictors of antioxidant supplement use during breast cancer treatment
The Long Island Breast Cancer Study Project
Article first published online: 8 JUN 2009
DOI: 10.1002/cncr.24378
Copyright © 2009 American Cancer Society
Additional Information
How to Cite
Greenlee, H., Gammon, M. D., Abrahamson, P. E., Gaudet, M. M., Terry, M. B., Hershman, D. L., Desai, M., Teitelbaum, S. L., Neugut, A. I. and Jacobson, J. S. (2009), Prevalence and predictors of antioxidant supplement use during breast cancer treatment. Cancer, 115: 3271–3282. doi: 10.1002/cncr.24378
Publication History
- Issue published online: 15 JUL 2009
- Article first published online: 8 JUN 2009
- Manuscript Accepted: 31 DEC 2008
- Manuscript Revised: 28 DEC 2008
- Manuscript Received: 15 OCT 2008
Funded by
- Lance Armstrong Foundation
- National Cancer Institute and National Institutes of Environmental Health and Sciences. Grant Numbers: U01CA/ES66572, U01CA66572, CA52283, P30ES10126
- National Cancer Institute. Grant Number: R25 CA09406
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort, Cancer, 2012, 118, 8Direct Link:
- 2, , Metals and Breast Cancer: Risk Factors or Healing Agents?, Journal of Toxicology, 2011, 2011, 1
- 3, , , , , , , , , , Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study, Breast Cancer Research and Treatment, 2011, 130, 1, 195
- 4, Vitamin Supplement Use During Breast Cancer Treatment and Survival: A Prospective Cohort Study, Breast Diseases: A Year Book Quarterly, 2011, 22, 4, 401
- 5, , , , Selenium: a double-edged sword for defense and offence in cancer, Archives of Toxicology, 2010, 84, 12, 919
- 6, , , , , , , Use of complementary and alternative therapy by women in the first 2 years after diagnosis and treatment of invasive breast cancer, Menopause, 2010, 17, 5, 1004

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)